Davidson, J A <br/><br/>
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Jul 2013 
 - 2469-75 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2013.03.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Breast Neoplasms--diagnosis<br/>Cost-Benefit Analysis<br/>Economics, Pharmaceutical<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Prospective Studies<br/>Receptors, Estrogen--biosynthesis<br/>Risk Assessment<br/>Risk Factors<br/>Transcriptome<br/>Young Adult